| 0 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
85 |
0.0027 |
| 1 |
Purine Antimetabolite [EPC] |
84 |
0.0008 |
| 2 |
Nitrofuran Antibacterial [EPC] |
13 |
0.0007 |
| 3 |
Selective T Cell Costimulation Modulator [EPC] |
81 |
0.0006 |
| 4 |
Type I Interferon Receptor Antagonist [EPC] |
1 |
0.0005 |
| 5 |
Aminoglycoside Antibacterial [EPC] |
16 |
0.0004 |
| 6 |
Macrolide Antimicrobial [EPC] |
18 |
0.0003 |
| 7 |
CD20-directed Cytolytic Antibody [EPC] |
77 |
0.0002 |
| 8 |
Tetracycline-class Drug [EPC] |
16 |
0.0002 |
| 9 |
Aminosalicylate [EPC] |
18 |
0.0002 |
| 10 |
Folate Analog Metabolic Inhibitor [EPC] |
71 |
0.0002 |
| 11 |
Antirheumatic Agent [EPC] |
17 |
0.0002 |
| 12 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
19 |
0.0001 |
| 13 |
Antimetabolite Immunosuppressant [EPC] |
3 |
0.0001 |
| 14 |
Tumor Necrosis Factor Blocker [EPC] |
121 |
0.0001 |
| 15 |
Fluoroquinolone Antibacterial [EPC] |
14 |
0.0001 |
| 16 |
Provitamin D2 Compound [EPC] |
3 |
0.0001 |
| 17 |
Human Immunoglobulin G [EPC] |
2 |
0.0001 |
| 18 |
Expectorant [EPC] |
13 |
0.0001 |
| 19 |
Sympathomimetic-like Agent [EPC] |
2 |
0.0001 |
| 20 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
1 |
0.0001 |
| 21 |
Interleukin-17A Antagonist [EPC] |
2 |
0.0001 |
| 22 |
Retinoid [EPC] |
12 |
0.0000 |
| 23 |
Corticosteroid [EPC] |
51 |
0.0000 |
| 24 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1 |
0.0000 |
| 25 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Alkaloid [EPC] |
1 |
0.0000 |
| 27 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Proton Pump Inhibitor [EPC] |
20 |
0.0000 |
| 29 |
Histamine-1 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 30 |
Anti-IgE [EPC] |
2 |
0.0000 |
| 31 |
Central Nervous System Stimulant [EPC] |
2 |
0.0000 |
| 32 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
2 |
0.0000 |
| 33 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 35 |
Ester Local Anesthetic [EPC] |
1 |
0.0000 |
| 36 |
Janus Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 37 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 38 |
Aromatic Amino Acid [EPC] |
1 |
0.0000 |
| 39 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
21 |
0.0000 |
| 40 |
Loop Diuretic [EPC] |
7 |
0.0000 |
| 41 |
Interleukin-6 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 42 |
Anti-epileptic Agent [EPC] |
3 |
0.0000 |
| 43 |
Non-Standardized Chemical Allergen [EPC] |
1 |
0.0000 |
| 44 |
Catecholamine [EPC] |
1 |
0.0000 |
| 45 |
Amide Local Anesthetic [EPC] |
1 |
0.0000 |
| 46 |
Nitrate Vasodilator [EPC] |
1 |
0.0000 |
| 47 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 48 |
Estrogen [EPC] |
2 |
0.0000 |
| 49 |
Progestin [EPC] |
3 |
0.0000 |
| 50 |
Osmotic Laxative [EPC] |
3 |
0.0000 |
| 51 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 52 |
Vitamin D [EPC] |
3 |
0.0000 |
| 53 |
Thiazide Diuretic [EPC] |
2 |
0.0000 |
| 54 |
Vitamin C [EPC] |
4 |
0.0000 |
| 55 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 56 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 57 |
Mood Stabilizer [EPC] |
2 |
0.0000 |
| 58 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 59 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 60 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 61 |
HMG-CoA Reductase Inhibitor [EPC] |
3 |
0.0000 |
| 62 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 63 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 64 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 65 |
Benzodiazepine [EPC] |
5 |
0.0000 |
| 66 |
Platelet Aggregation Inhibitor [EPC] |
4 |
0.0000 |
| 67 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 68 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 69 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 70 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 71 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 72 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |